The project shall be launched first in Mandla, one of the most malaria endemic districts of Madhya Pradesh. Sun Pharma will fund as well as execute this programme over a span of three to five years, covering over 2,00,000 households in Mandla.
India’s largest pharmaceutical company Sun Pharmaceuticals on Monday entered into a public private partnership (PPP) with the Union and Madhya Pradesh Governments for a campaign to ensure a malaria-free India.
In this partnership, the three stakeholders will establish a phased malaria eradication project for most endemic districts of Madhya Pradesh.
Moreover, the company and the Indian Council of Medical Research (ICMR) may enter a joint drug development programme to manufacture new patented drugs. ICMR comes under the Union ministry of health and family welfare.
-
The other stakeholder in the partnership is the Madhya Pradesh government
-
Mandla district in the state to be targeted first
-
Sun Pharma may also enter a joint drug development programme to manufacture new patented drugs
-
Aim of the PPP is to completely eradicate malaria in three to five years